Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex321_6.htm |
EX-31.2 - EX-31.2 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex312_8.htm |
EX-31.1 - EX-31.1 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex311_7.htm |
EX-23.1 - EX-23.1 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex231_713.htm |
EX-10.31 - EX-10.31 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex1031_817.htm |
EX-10.30 - EX-10.30 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex1030_714.htm |
EX-10.29 - EX-10.29 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex1029_715.htm |
10-K - 10-K - HTG MOLECULAR DIAGNOSTICS, INC | htgm-10k_20171231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of HTG Molecular Diagnostics, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: March 22, 2018 |
|
By: |
/s/ Shaun D. McMeans |
|
|
|
Shaun D. McMeans |
|
|
|
Chief Financial Officer (Principal Financial and Accounting Officer) |